[{"notes_id":"1_206","category":"12","subcategory":"0","title":"Acute asthma: management","body":"The British Thoracic Society (BTS) classify patients with acute asthma into moderate, severe or life-threatening categories.<br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Moderate<\/b><\/th><th><span class=\"concept\" data-cid=\"5448\"><b>Severe<\/b><\/span><\/th><th><b>Life-threatening<\/b><\/th><\/tr><\/thead><tbody><tr><td> <span class=\"concept\" data-cid=\"6413\">PEFR 50-75% best or predicted<\/span><br \/> <span class=\"concept\" data-cid=\"6414\">Speech normal<\/span><br \/> <span class=\"concept\" data-cid=\"6415\">RR < 25 \/ min<\/span><br \/> <span class=\"concept\" data-cid=\"6416\">Pulse < 110 bpm<\/span><\/td><td><span class=\"concept\" data-cid=\"6417\">PEFR 33 - 50% best or predicted<\/span><br \/> <span class=\"concept\" data-cid=\"4144\">Can't complete sentences<\/span><br \/> <span class=\"concept\" data-cid=\"6419\">RR > 25\/min<\/span><br \/> <span class=\"concept\" data-cid=\"6420\">Pulse > 110 bpm<\/span><\/td><td><span class=\"concept\" data-cid=\"6421\">PEFR < 33% best or predicted<\/span><br \/> <span class=\"concept\" data-cid=\"6422\">Oxygen sats < 92%<\/span><br \/><span class=\"concept\" data-cid=\"1463\">'Normal' pCO<sub>2<\/sub> (4.6-6.0 kPa)<\/span><br \/> <span class=\"concept\" data-cid=\"6423\">Silent chest, cyanosis or feeble respiratory effort<\/span><br \/> <span class=\"concept\" data-cid=\"6424\">Bradycardia, dysrhythmia or hypotension<\/span><br \/> <span class=\"concept\" data-cid=\"6425\">Exhaustion<\/span>, <span class=\"concept\" data-cid=\"1485\">confusion<\/span> or coma<\/td><\/tr><\/tbody><\/table><\/div><br \/>Note that a patient having any one of the life-threatening features should be treated as having a life-threatening attack.<br \/><br \/>A fourth category, '<b>Near-fatal asthma<\/b>', is also recognised characterised by a <span class=\"concept\" data-cid=\"4472\">raised pCO<sub>2<\/sub><\/span> and\/or requiring mechanical ventilation with raised inflation pressures.<br \/><br \/>Further assessment<br \/><ul><li>the BTS guidelines recommend <span class=\"concept\" data-cid=\"10910\">arterial blood gases for patients with oxygen sats < 92%<\/span><\/li><li>a chest x-ray is not routinely recommended, unless:<ul><li>life-threatening asthma<\/li><li>suspected pneumothorax<\/li><li>failure to respond to treatment<\/li><\/ul><\/li><\/ul><br \/>Management<br \/><ul><li>admission<ul><li>all patients with life-threatening should be admitted in hospital<\/li><li>patients with features of severe acute asthma should also be admitted if they fail to respond to initial treatment.<\/li><li>other admission criteria include a <span class=\"concept\" data-cid=\"1501\">previous near-fatal asthma attack<\/span>, <span class=\"concept\" data-cid=\"10907\">pregnancy<\/span>, an attack occurring despite already using oral corticosteroid and presentation at night<\/li><\/ul><\/li><li>oxygen<ul><li>if patients are hypoxaemic, it is important to start them on supplemental oxygen therapy<\/li><li>if patients are acutely unwell they should be started on 15L of supplemental via a non-rebreathe mask, which can then be titrated down to a flow rate where they are able to maintain a <span class=\"concept\" data-cid=\"10908\">SpO\u201a\u201a 94-98%<\/span>.<\/li><\/ul><\/li><li>bronchodilation with short-acting beta\u201a\u201a-agonists (SABA)<ul><li>high-dose inhaled SABA e.g. salbutamol, terbutaline<\/li><li>in patients without features of life-threatening or near-fatal asthma, this can be given by a standard pressurised metered-dose inhaler (pMDI) or by an oxygen-driven nebulizer<\/li><li>in patients with features of a life-threatening exacerbation of asthma, <span class=\"concept\" data-cid=\"1605\">nebulised SABA<\/span> is recommended<\/li><\/ul><\/li><li>corticosteroid<ul><li>all patients should be given 40-50mg of <span class=\"concept\" data-cid=\"11822\">prednisolone orally<\/span> (PO) daily, which should be continued for at least five days or until the patient recovers from the attack<\/li><li>during this time, patients should continue their normal medication routine including inhaled corticosteroids.<\/li><\/ul><\/li><li><span class=\"concept\" data-cid=\"10909\">ipratropium bromide: in patients with severe or life-threatening asthma<\/span>, or in patients who have not responded to beta\u201a\u201a-agonist and corticosteroid treatment, nebulised ipratropium bromide, a short-acting muscarinic antagonist<\/li><li>IV magnesium sulphate<ul><li>the BTS notes that the evidence base is mixed for this treatment that is now commonly given for severe\/life-threatening asthma<\/li><\/ul><\/li><li>IV aminophylline may be considered following consultation with senior medical staff<\/li><li>patients who fail to respond require <span class=\"concept\" data-cid=\"5561\">senior critical care support<\/span> and should be treated in an appropriate ITU\/HDU setting. Treatment options include:<ul><li><span class=\"concept\" data-cid=\"12063\">intubation and ventilation<\/span><\/li><li>extracorporeal membrane oxygenation (ECMO)<\/li><\/ul><\/li><\/ul><br \/>Criteria for discharge<br \/><ul><li>been <span class=\"concept\" data-cid=\"10912\">stable on their discharge medication (i.e. no nebulisers or oxygen) for 12-24 hours<\/span><\/li><li><span class=\"concept\" data-cid=\"11365\">inhaler technique checked and recorded<\/span><\/li><li><span class=\"concept\" data-cid=\"10911\">PEF >75% of best or predicted<\/span><\/li><\/ul>","notes_hash":"bd67d4c0d520a9e30fd538ab6bd8815d","knowledge_graph_node_id_link":0,"links":"<table style='width:100%'><tr><td>British Thoracic Society<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_191\" data-linkid=\"191\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_191\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">69<\/span><button type=\"button\" style=\"\" id=\"link_dislike_191\" data-linkid=\"191\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_191\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">134<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/www.brit-thoracic.org.uk\/document-library\/guidelines\/asthma\/btssign-asthma-guideline-quick-reference-guide-2019\/\">2019 Asthma guidelines<\/a><\/td><\/tr><\/table>","media":"","concepts_for_notes":{"1605":{"concept_text":"Nebulised salbutamol delivered in O2 is the first line management for acute severe asthma with life-threatening features","concept_percentile":"98"},"4144":{"concept_text":"If a patient cannot complete sentences, they have severe asthma","concept_percentile":"59"},"6413":{"concept_text":"Moderate asthma  PEFR  50-75% best or predicted","concept_percentile":"10"},"6414":{"concept_text":"Moderate asthma  speech normal","concept_percentile":"39"},"6415":{"concept_text":"Moderate asthma  RR < 25 \/ min","concept_percentile":"16"},"6416":{"concept_text":"Moderate asthma  pulse < 110 bpm","concept_percentile":"16"},"6417":{"concept_text":"Severe asthma  PEFR 33 - 50% best or predicted","concept_percentile":"11"},"6419":{"concept_text":"Severe asthma  RR > 25\/min","concept_percentile":"23"},"6420":{"concept_text":"Severe asthma  pulse > 110 bpm","concept_percentile":"26"},"6421":{"concept_text":"Life-threatening asthma  PEFR < 33% best or predicted","concept_percentile":"18"},"6422":{"concept_text":"Life-threatening asthma  oxygen sats < 92%","concept_percentile":"64"},"6423":{"concept_text":"Life-threatening asthma  silent chest, cyanosis or feeble respiratory effort","concept_percentile":"31"},"6424":{"concept_text":"Life-threatening asthma  bradycardia, dysrhythmia or hypotension","concept_percentile":"34"},"6425":{"concept_text":"Life-threatening asthma  exhaustion, confusion or coma","concept_percentile":"45"},"10909":{"concept_text":"Nebulised ipratropium bromide should be given to all patients with severe or life-threatening asthma","concept_percentile":"95"},"11365":{"concept_text":"Inhaler technique should be checked and recorded before discharging a patient who has been admitted with acute asthma","concept_percentile":"94"},"12063":{"concept_text":"Patient with acute asthma who do not respond to full medical treatment and are becoming acidotic should be intubated and ventilated, rather than given BiPAP\/CPAP","concept_percentile":"99"}},"category_name":"Respiratory","subcategory_name":"","comment_count":12},"",[]]